Associate Professor, at Isfahan University of Medical Sciences, Iran.
📌 Dr. Nafiseh Esmaeil is an esteemed Iranian immunologist specializing in clinical immunology and immunotherapy. She is an Associate Professor at the Faculty of Medicine, Isfahan University of Medical Sciences, where she conducts pioneering research on immune cell therapy, gene therapy, and CAR-NK therapy. With a strong academic background, she has contributed significantly to the field through her research, publications, and mentorship. Dr. Esmaeil is actively involved in various national and international immunology societies and serves as a reviewer for multiple high-impact journals. Her dedication to immunopharmacology and immune cell products has earned her recognition as an honored researcher.
Professional Profile
Scopus
ORCID
Google Scholar
Education 🎓
Dr. Nafiseh Esmaeil has pursued a rigorous academic journey in medical sciences. She completed her High School Diploma at Hashtom Shahrivar High School in Isfahan in 1991. She earned her B.Sc. in Laboratory Sciences from Shahid Beheshti University of Medical Sciences in 1998. She further specialized in Clinical Immunology, obtaining an M.Sc. from Mashhad University of Medical Sciences in 2002. Her passion for immunology led her to pursue a Ph.D. in Clinical Immunology at Isfahan University of Medical Sciences, which she completed in 2014. Her academic achievements have laid a strong foundation for her contributions to immunotherapy and immunopharmacology.
Experience 💼
Dr. Esmaeil has an extensive teaching and research career in medical immunology. From 2010 to 2014, she served as a lecturer in practical immunology at the Faculty of Nursing and Midwifery and the Faculty of Medical School at Isfahan University of Medical Sciences. In 2014, she was appointed Assistant Professor of Medical Immunology and, in 2019, was promoted to Associate Professor. Her work involves teaching, research, and supervision of postgraduate students. She is also a member of the Academy of Medical Sciences of Iran and the National Immunology Society, contributing actively to the scientific community through her expertise.
Research Interests 🔬
Dr. Esmaeil’s research interests lie at the intersection of immunotherapy and immunopharmacology. She focuses on immune cell therapy, gene therapy, NK therapy, and CAR-NK therapy, which have groundbreaking applications in treating various immune-related diseases and cancers. Her work also delves into immune cell products, including extracellular vesicles, aiming to enhance targeted therapies. Her research contributes to developing innovative treatments that improve patient outcomes in immunological and oncological disorders.
Awards 🏆
Dr. Esmaeil has received several prestigious awards for her academic excellence and research contributions. In December 2012, she was honored as an outstanding Ph.D. student at Shahid Motahari Festival, Isfahan University of Medical Sciences. The same year, she was recognized as an honored Ph.D. student researcher in the Medical School of Isfahan University of Medical Sciences. These accolades highlight her commitment to advancing immunology and her dedication to scientific discovery.
Top Noted Publications 📚
Dr. Esmaeil has an impressive portfolio of scientific publications in high-impact journals. Her research has significantly contributed to the field of immunology, earning her an H-index of 19. Some of her notable publications include:
- Different Behavior of NK Cells Isolated from Healthy Women and Women with Recurrent Spontaneous Abortion (RSA) after Treatment with Human Amniotic Epithelial Cells (hAECs) – Journal of Leukocyte Biology, 2025. [Accepted]
- Liposomal AZD5363 Displays Antiproliferation Activities and Induces Apoptosis on Y79 Retinoblastoma Cancer Cells – South Asian Journal of Cancer, 2024.
- Evaluation of the Natural Killer Cell Subsets and Their Relationship with Serum Interferon Gamma and Vitamin D Levels in Women with Stages III and IV Endometriosis: A Case-Control Study – International Journal of Reproductive BioMedicine, 2024.
- Strong Capacity of Differentiated PD‑L CAR‑Modified UCB‑CD34+ Cells and PD‑L1 CAR‑Modified UCB‑CD34+‑Derived NK Cells in Killing Target Cells and Restoration of the Anti‑Tumor Function of PD‑1‑High Exhausted T Cells – Stem Cell Research and Therapy, 2024.
- More Balance Toward Activating Receptors and Cytotoxic Activity of NK Cells Ex Vivo Differentiated from Human Umbilical Cord Blood-Derived CD34+ Stem Cells in Comparison with Peripheral Blood NK Cells – Heliyon, 2024.
- Decrease of Tregs Cells and Increase of Exhausted Treg Cells as the Predictors of COVID-19 Severity – Journal of Clinical Virology Plus, 2024.
- Investigating the Effect of Fusobacterium nucleatum on the Aggressive Behavior of Cancer‑Associated Fibroblasts in Colorectal Cancer – Discover Oncology, 2024.
- Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease – Genes, 2024.
- Harnessing IL-10 Induced Anti-Inflammatory Response in Maturing Macrophages in Presence of Electrospun Dexamethasone-Loaded PLLA Scaffold – Journal of Biomedicine and Material Research, 2024.
- A 2-Week Combined High-Intensity Interval Training Regulates Inflammatory Status in Young Females with Obesity – Sport and Science, 2023.
Conclusion
Dr. Nafiseh Esmaeil is a highly qualified candidate for the Research for Women Researcher Award, given her strong publication record, contributions to immunology, academic achievements, and research impact. To further solidify her application, she could expand her international research collaborations, highlight funding successes, and emphasize her role in mentoring female scientists.